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An acid proteinase of granulomatous tissues in rats with carrageenin-induced inflammation released kinin 
from T-kininogen. The kinin isolated by n-butanol extraction was separated by reverse-phase high-perform- 
ance liquid chromatography into T-kinin and a T-kinin derivative. From determination of its amino acid 
composition and its immunoreactivity toward anti-bradykinin antiserum, the T-kinin derivative was identi- 
fied as Met-Ile-Ser-bradykinin (Met-T-kinin). 
T-Kinin; Met-T-kinin; Acid proteinase; (Rat granulomatous tissue) 
1. INTRODUCTION 
Previously, we have reported that the release of 
T-kinin from T-kininogen occurred by consecutive 
cleavage by a cathepsin E-like proteinase and a 
72 kDa proteinase in rat spleen [l]. However, it 
has not yet been clarified whether T-kinin could be 
released from T-kininogen by granulomatous 
tissues in rats with carrageenin-induced inflamma- 
tion, although T-kininogen and free T-kinin have 
been reported to increase in the plasma and pouch 
fluid of rats with carrageenin-induced inflamma- 
tion [2,3]. This paper reports that both Ile-Ser- 
bradykinin (T-kinin) and Met-Ile-Ser-bradykinin 
(Met-T-kinin) are released from T-kininogen by an 
acid proteinase of granulomatous tissues in rats 
with carrageenin-induced inflammation. 
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T-kininogen (spec. act. 9.2 pg bradykinin 
equiv./mg protein) was prepared from rat plasma 
as in [4]. Synthetic bradykinin, Lys-bradykinin, 
Met-Lys-bradykinin and T-kinin were purchased 
from the Protein Research Foundation (Osaka). 
Granulomatous tissues were collected on days 
5-20 after carrageenin injection into rats, as 
described [2]. The acid proteinase from 
granulomatous tissues was partially purified by 
chromatography on DEAE-Sephadex A-50 and 
Sephadex G-100, according to [l]. The specific ac- 
tivity of the acid proteinase was 0.67 U/Azso with 
hemoglobin as substrate. Acid proteinase and 
kinin-releasing activities were measured as in [l]. 
The amount of kinin was determined by a bioassay 
using rat uterus [5] and by an enzyme im- 
munoassay [6]. 
3. RESULTS 
Abbreviation: HPLC, high-performance liquid Purified T-kininogen (2 mg protein) was 
chromatography digested with the acid proteinase (0.4 U) at 37°C 
2. MATERIALS AND METHODS 
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for 60 min in 12.0 ml of 0.2 M glycine-HCI buffer 
(pH 3.6) containing 2 mM EDTA. The reaction 
was terminated by acidifying the mixture to pH 2.5 
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Fig. 1. Reverse-phase HPLC of kinin released from T-kininogen by acid proteinase (A) and of synthetic kinins (B). (A) 
The released kinin (0.7,~g bradykinin equiv.), which was extracted with n-butanol and lyophilized according to 
Okamoto and Greenbaum [7], was injected into the reverse-phase column (ODS-120T, 0.46 x 25 cm). The column was 
eluted isocratically with 20% acetonitrile in 0.05% trifluoroacetic acid at a flow rate of 1 .O ml/min. Fractions of 1 .O ml 
were collected. (O - - s O) Rat uterus contracting activity. (B) 200 ng synthetic bradykinin and its derivatives. The kinin 
activity of each fraction was determined by a bioassay using rat uterus and enzyme immunoassay using bradykinin as 
a standard. 
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Table 1 
Amino acid compositions of kinins (K-l and K-2) released from T-kininogen 
by acid proteinase of granulomatous tissues in rats 
Amino acid K-l K-2 
nmol mol/mol Residue/ nmol mol/mol Residue/ 
Ile molecule Ile molecule 
Ser 5.3 1.9 2 6.7 1.8 2 
Pro 9.1 3.2 3 11.6 3.1 3 
GlY 3.8 1.4 1 4.6 1.2 1 
Ile 2.8 1.0 1 3.7 1.0 1 
Phe 5.3 1.9 2 7.6 2.1 2 
Arg 5.0 1.8 2 7.3 2.0 2 
Met - - - 2.8 0.8 1 
Purified K-l (3.3 pg) and K-2 (5.5 pug) were hydrolyzed with 6 N HCI at 
110°C for 24 h in evacuated and sealed tubes. The hydrolysates were 
evaporated and analyzed in a Hitachi-835 amino acid analyzer. The amounts 
of kinins were calculated from the area of HPLC 
July 1987 
(ODS-120 T, Toyo Soda, Japan). As shown in 
fig.lA, the kinin, determined by measuring rat 
uterus contracting activity, was thereby separated 
into two fractions (K-l, K-2). The retention time 
(21.76 min) of K-l was identical with that of syn- 
thetic T-kinin (fig.lB). Therefore, K-l was iden- 
tified as T-kinin. However, the retention time 
(33.70 min) of K-2 differed from those of Met- 
Lys-bradykinin, Lys-bradykinin and bradykinin. 
The weight ratio of K-l and K-2 liberated from T- 
kininogen was estimated to be 0.48 from peak 
areas on HPLC. 
In order to characterize K-2, its amino acid com- 
position, immunoreactivity in the enzyme im- 
munoassay, and uterus contracting activity were 
compared with those of T-kinin (K-l). The amino 
acid composition of K-2 showed one additional 
Met residue in comparison with that of T-kinin, as 
shown in table 1. In the enzyme immunoassay, K-2 
had virtually equal immunoreactivity to T-kinin, 
but the contracting activity on rat uterus was 63% 
in comparison with that of T-kinin. From these 
results the amino acid sequence of K-2 is assumed 
to be: Met-Ile-Ser-Arg-Pro-Pro-Gly-Phe-Ser-Pro- 
Phe-Arg (Met-T-kinin, A4, 13 15). 
4. DISCUSSION 
In mammals, four types of kinin, i.e. 
bradykinin, Lys-bradykinin, Met-Lys-bradykinin 
and Ile-Ser-bradykinin (T-kinin), can be generated 
from three types of kininogen [8]. Here, it has been 
shown that a fifth kinin can be released from T- 
kininogen by an acid proteinase of granulomatous 
tissues and this kinin has been identified as Met- 
Ile-Ser-bradykinin (Met-T-kinin). From nucleotide 
sequencing of rat T-prekininogen I mRNA, 
Nakanishi et al, [9] have reported that T-kininogen 
harbors an Ile-Ser-bradykinin sequence preceded 
by the dipeptide Met-Met. Therefore, the acid pro- 
teinase of granulomatous tissues seems to release 
both T-kinin and Met-T-kinin by cleavage of the 
Met-Met and Met-Ile bonds. However, it is not 
yet clear whether T-kinin was produced from Met- 
T-kinin or directly from T-kininogen by the acid 
proteinase, because the acid proteinase prepara- 
tion used in this study still showed several bands on 
SDS-polyacrylamide gel electrophoresis. In a 
preliminary experiment, where the acid proteinase 
was further purified by column chromatography 
on DEAE-Sephadex A-50 and pepstatin-Sepharose 
4B, two types of acid proteinase seemed to be 
responsible for the kinin release, as was the case 
for the release of T-kinin by consecutive cleavage 
by the cathepsin E-like proteinase and the 72 kDa 
proteinase of rat spleen [l]. The characterization 
of acid proteinase (kinin-releasing enzyme) of 
granulomatous tissues is now underway. 
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